Dimension Therapeutics, Inc. Stock or Unit Option Plan Expense
Dimension Therapeutics, Inc. reported Stock or Unit Option Plan Expense of $279.00 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:StockOptionPlanExpense · last filed 2017-11-06
- Dimension Therapeutics, Inc. stock or unit option plan expense for the quarter ending 2017-09-30 was $279.00K.
- Dimension Therapeutics, Inc. stock or unit option plan expense for the quarter ending 2017-06-30 was $28.00K.
| Period end | Stock or Unit Option Plan Expense 3 month | Stock or Unit Option Plan Expense 6 month | Stock or Unit Option Plan Expense 9 month |
|---|---|---|---|
| 2017-09-30 | $279.00K 10-Q · filed 2017-11-06 | $307.00K derived: sum of 2 quarters · filed 2017-11-06 | $307.00K 10-Q · filed 2017-11-06 |
| 2017-06-30 | $28.00K 10-Q · filed 2017-08-08 | $28.00K 10-Q · filed 2017-08-08 |